Stock listing
NASDAQ:VVOS Vivos Therapeutics, Inc. Stock
Home listing (NASDAQ) of Vivos Therapeutics, Inc.
Follow Vivos Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VVOS
$0.135 USD +0.004 (+2.9%)
Close on Oct 19, 2026
- Day range
- $0.125 – $0.135 USDOct 19, 2026
- Volume
- 3.90M sharesOct 19, 2026
- Market cap
- $4.54M USDAt the close on Oct 19, 2026 · price × 33.64M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VVOS · Home | $0.135 USD | +0.004 (+2.9%) | 3,897,282 | $0.135 | $0.135 | $0.125 | $0.131 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:VVOS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.135 | +0.004 | +2.9% | $0.135 | $0.135 | $0.125 | 3,897,282 | |
| $0.131 | -0.012 | -8.2% | $0.143 | $0.143 | $0.128 | 1,617,497 | |
| $0.143 | +0.009 | +6.6% | $0.134 | $0.150 | $0.128 | 11,140,459 | |
| $0.134 | -0.008 | -5.4% | $0.138 | $0.145 | $0.134 | 670,645 | |
| $0.142 | -0.002 | -1.7% | $0.146 | $0.146 | $0.136 | 734,778 | |
| $0.144 | -0.005 | -3.4% | $0.150 | $0.150 | $0.140 | 483,500 | |
| $0.149 | -0.001 | -0.7% | $0.150 | $0.160 | $0.144 | 8,832,200 | |
| $0.150 | -0.001 | -0.7% | $0.151 | $0.154 | $0.146 | 1,977,100 | |
| $0.151 | -0.003 | -1.9% | $0.154 | $0.157 | $0.145 | 419,000 | |
| $0.154 | 0.000 | 0.0% | $0.154 | $0.160 | $0.151 | 572,900 | |
| $0.154 | +0.002 | +1.3% | $0.150 | $0.158 | $0.147 | 580,800 | |
| $0.152 | +0.003 | +2.0% | $0.152 | $0.155 | $0.147 | 667,400 | |
| $0.149 | +0.001 | +0.7% | $0.144 | $0.152 | $0.143 | 1,198,200 | |
| $0.148 | -0.003 | -2.0% | $0.141 | $0.151 | $0.141 | 2,276,600 | |
| $0.151 | +0.017 | +12.7% | $0.138 | $0.156 | $0.129 | 76,758,300 | |
| $0.134 | -0.007 | -5.0% | $0.138 | $0.140 | $0.130 | 1,451,100 | |
| $0.141 | -0.005 | -3.4% | $0.147 | $0.147 | $0.140 | 653,800 | |
| $0.146 | -0.003 | -2.0% | $0.144 | $0.147 | $0.142 | 928,800 | |
| $0.149 | -0.008 | -5.1% | $0.161 | $0.161 | $0.140 | 1,544,900 | |
| $0.157 | -0.003 | -1.9% | $0.159 | $0.169 | $0.154 | 1,096,600 | |
| $0.160 | -0.003 | -1.8% | $0.167 | $0.167 | $0.158 | 678,900 | |
| $0.163 | -0.013 | -7.4% | $0.170 | $0.170 | $0.158 | 1,668,000 | |
| $0.176 | +0.015 | +9.3% | $0.165 | $0.180 | $0.161 | 1,820,000 | |
| $0.161 | -0.003 | -1.8% | $0.161 | $0.165 | $0.156 | 1,366,100 | |
| $0.164 | -0.013 | -7.3% | $0.171 | $0.175 | $0.158 | 1,553,100 | |
| $0.177 | -0.007 | -3.8% | $0.179 | $0.181 | $0.172 | 1,137,200 | |
| $0.184 | +0.002 | +1.1% | $0.183 | $0.186 | $0.175 | 1,521,100 | |
| $0.182 | +0.012 | +7.1% | $0.165 | $0.183 | $0.165 | 2,703,900 | |
| $0.170 | -0.010 | -5.6% | $0.168 | $0.190 | $0.165 | 46,274,000 | |
| $0.180 | -0.006 | -3.2% | $0.182 | $0.193 | $0.174 | 5,087,500 | |
| $0.186 | +0.011 | +6.3% | $0.164 | $0.189 | $0.164 | 4,503,900 | |
| $0.175 | +0.002 | +1.2% | $0.170 | $0.180 | $0.167 | 4,055,900 | |
| $0.173 | +0.004 | +2.4% | $0.158 | $0.180 | $0.158 | 7,570,800 | |
| $0.169 | -0.027 | -13.8% | $0.164 | $0.177 | $0.162 | 18,303,400 | |
| $0.196 | -0.029 | -12.9% | $0.395 | $0.456 | $0.167 | 532,182,700 | |
| $0.225 | -0.033 | -12.8% | $0.255 | $0.272 | $0.221 | 4,731,200 | |
| $0.258 | +0.004 | +1.6% | $0.250 | $0.263 | $0.240 | 1,783,800 | |
| $0.254 | -0.011 | -4.2% | $0.260 | $0.268 | $0.251 | 15,185,100 | |
| $0.265 | -0.012 | -4.3% | $0.281 | $0.282 | $0.260 | 1,771,800 | |
| $0.277 | -0.020 | -6.7% | $0.300 | $0.300 | $0.274 | 246,100 | |
| $0.297 | +0.018 | +6.5% | $0.288 | $0.300 | $0.280 | 122,500 | |
| $0.279 | +0.003 | +1.1% | $0.273 | $0.285 | $0.270 | 490,200 | |
| $0.276 | -0.018 | -6.1% | $0.290 | $0.298 | $0.260 | 402,200 | |
| $0.294 | -0.007 | -2.3% | $0.299 | $0.299 | $0.294 | 176,000 | |
| $0.301 | -0.042 | -12.2% | $0.305 | $0.322 | $0.301 | 661,000 | |
| $0.343 | +0.038 | +12.5% | $0.307 | $0.364 | $0.296 | 1,731,000 | |
| $0.305 | +0.019 | +6.6% | $0.287 | $0.315 | $0.280 | 703,800 | |
| $0.286 | -0.029 | -9.2% | $0.309 | $0.309 | $0.271 | 1,170,800 | |
| $0.315 | -0.003 | -0.9% | $0.332 | $0.360 | $0.290 | 5,979,800 | |
| $0.318 | -0.006 | -1.9% | $0.326 | $0.338 | $0.315 | 711,400 | |
| $0.324 | +0.002 | +0.6% | $0.318 | $0.354 | $0.310 | 1,329,400 | |
| $0.322 | -0.019 | -5.6% | $0.337 | $0.345 | $0.320 | 1,309,900 | |
| $0.341 | -0.121 | -26.2% | $0.310 | $0.348 | $0.302 | 7,626,400 | |
| $0.462 | +0.041 | +9.7% | $0.425 | $0.540 | $0.420 | 35,483,300 | |
| $0.421 | +0.011 | +2.7% | $0.420 | $0.433 | $0.412 | 111,000 | |
| $0.410 | +0.004 | +1.0% | $0.406 | $0.420 | $0.394 | 186,100 | |
| $0.406 | -0.008 | -1.9% | $0.420 | $0.426 | $0.404 | 38,600 | |
| $0.414 | -0.006 | -1.4% | $0.440 | $0.440 | $0.410 | 228,400 | |
| $0.420 | +0.017 | +4.2% | $0.405 | $0.430 | $0.380 | 232,400 | |
| $0.403 | +0.010 | +2.5% | $0.417 | $0.417 | $0.386 | 131,100 | |
| $0.393 | +0.002 | +0.5% | $0.383 | $0.410 | $0.364 | 152,600 | |
| $0.391 | -0.013 | -3.2% | $0.398 | $0.410 | $0.390 | 285,600 | |
| $0.404 | -0.011 | -2.7% | $0.410 | $0.416 | $0.404 | 125,000 | |
| $0.415 | +0.004 | +1.0% | $0.418 | $0.420 | $0.401 | 110,900 | |
| $0.411 | -0.009 | -2.1% | $0.430 | $0.440 | $0.405 | 71,000 |
- Ticker
- NASDAQ:VVOS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 20, 2026
SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
Latest earnings call · Aug 14, 2026
Vivos Therapeutics (NASDAQ:VVOS) Q2 2026 Earnings Call
Replay and transcript
Calls
Replays
Vivos Therapeutics (NASDAQ:VVOS) Q2 2026 Earnings Call
Fri, Aug 14, 2026 · 5:00 PM ET
Watch TranscriptVivos Therapeutics (NASDAQ:VVOS) Q1 2026 Earnings Call
Wed, May 20, 2026 · 5:00 PM ET
Watch TranscriptVivos Therapeutics (NASDAQ:VVOS) Q4 2025 Earnings Call
Wed, Apr 15, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
Oct 15, 2026
Closed $0.143 (+6.6%) on Oct 15, 2026
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
Sep 29, 2026
Closed $0.151 (+12.7%) on Sep 29, 2026
Vivos Therapeutics Announces Material Debt Reduction
Sep 8, 2026
Closed $0.18 (-3.2%) on Sep 8, 2026
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
Sep 1, 2026
Closed $0.169 (-13.8%) on Sep 1, 2026
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
Aug 28, 2026
Closed $0.225 (-12.8%) on Aug 28, 2026
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
Aug 25, 2026
Closed $0.265 (-4.3%) on Aug 25, 2026
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
Aug 20, 2026
Closed $0.279 (+1.1%) on Aug 20, 2026
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
Aug 14, 2026
Closed $0.343 (+12.5%) on Aug 14, 2026
Vivos Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 31 in the last 12 months · 138 in all · newest Oct 20, 2026 · oldest 2020
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 14, 2026
Where Vivos Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VVOS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VVOS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Vivos Therapeutics, Inc.